There are a few lichenoid papules on the arms and some papules below the eyes due to follicular plugging. Over the greater part of the back and buttocks there is a severe degree of follicular hyperkeratosis, resembling lichen spinulosus.
The pigmentation and follicular hyperkeratosis are less now than they were a month ago. Investigation (23.1.48).-W.R. and Kahn negative.
Blood-count: R.B.C. 5-51 million; Hb. 1100% (Haldane); C.I. 1 0; W.B.C. 12,400, neutros. 80%, eosinos. 4%, lymphos. 9%, large monos. 7%. Urine normal. Dr. W. G. Tillman: Those in the Services saw a number of lichenoid eruptions due to mepacrine. I can remember one with the same form of spiny eruption. I should have thought the papules on the forearms, neck and face and legs were compatible with the diagnosis, though it did occur to me that the pigmentation on the chest and the patches on the upper arm might be tinea versicolor and I would suggest a scraping being examined.
Dr. R. M. B. MacKenna: I thought of pityriasis versicolor when I saw the colour of the skin. I have not seen lesions resembling lichen spinulosus in so-called tropical lichenoid dermatitis but I know they have been described. In this case there are two forms of follicular lesions, viz. spiny and rounded. Possibly the latter are a sign of avitaminosis. It has been suggested in the American literature that in tropical lichenoid dermatitis there may be some fault of the gastric or intestinal mucosz whereby there is faulty absorption of vitamin A. I would like to ask whether anyone examined the patient's finger nails under a Wood's ray? I have not had the opportunity of making this examination but I believe that in patients who have been taking mepacrine the nails show an unusual type of fluorescence.
Dr. Sanmman: Scrapings for fungus have not been made. I did, however, examine him under the Wood's light and except for the extraordinarily beautiful colour of his hair from some oil he was using, he showed nothing at all. He has improved during the month we have had him under observation. He has had large doses of vitamin A and a good diet.
POSTSCRIPT.-Scrapings from the pigmented areas have subsequently been examined but no evidence of tinea versicolor or other fungus has been found. When first seen by us there were multiple nodules, a trophic ulcer on the right foot and nervous involvement of the chest and upper and lower limbs. An excised papule showed a typical histological picture with large numbers of My. leprce, and nasal swabs were also positive. Treatment with sulphetrone by the mouth commenced in October 1942. A dosage of 1-5 grammes for five days was gradually increased to 6-0 grammes daily, and for a short period 7-0 grammes daily were taken; fluids were restricted to 3 pints (17 litres) daily. The drug was administered continuously over a period of fifteen months. Adjuvant treatment consisted of ferrous sulphate 3 grains twice daily. There were no toxic manifestations. Haemoglobin, averaging 70 %, fell on one occasion to 600% and blood levels of sulphetrone varied between 2 and 3 mg. per 100 ml.
All nodules were absorbed during treatment and no fresh ones have appeared. Nasal swabs became negative after twelve months' treatment and have remained so.
There has been no extension of nervous involvement and the same areas show anesthesia but tactile sensation in the fingers has improved as shown by the fact that the patient is now able to count and distinguish coins in his pocket. The general health of the patient has improved considerably and he has put on weight.
Several reports from Nigeria and India have recently appeared concerning the good results obtained with sulphetrone in the treatment of leprosy and we thought it would be interesting to show the first case treated with this preparation.
Dr. G. Brownlee: The interest in drugs of the "sulphetrone" type arose from the demonstration of the potent antibacterial activity of diaminodiphenylsulphone described by Buttle and others in 1937. It was the chemotherapeutic efficiency of the drug which stimulated our chemical colleagues to prepare a series of derivatives which would retain the activity but without the toxicity of the parent compound. Between 1936 and 1940, a series of Schiff's bases had been studiedand appeared to give a favourable lead. Two derivatives, piperonylideneand cinnamylidenediaminodiphenylsulphone, justified a complete pharmacological study. They proved satisfactory from the antibacterial aspect, particularly against acid-fast organisms, but had to be rejected because of their tendency to produce peripheral neuritis. However, the progress made justified the testing of soluble derivatives which might prove to be free from these defects, and my attention was directed to a soluble derivative first prepared in 1936. This was sulphetrone. Its chemical name is tetrasodium 4: 4'-bis (y-phenylpropylamino)-diphenylsulphone-a: y: a': y'-tetrasulphonate. It is insoluble in alcohol and other organic solvents but is exceedingly soluble in cold water. Brownlee, Green and Woodbine (1948) described its structure, chemical and physical properties, its pharmacology, experimental therapy and possible clinical uses. This was followed by a description (Brownlee and Kennedy, 1948a) of the suppressive effect of sulphetrone on progressive experimental tuberculosis in groups of guinea-pigs. The drug was found to be bacteriostatic in action. In a second study (Brownlee and Kennedy, 1948b) showed sulphetrone to be more efficient than promin in protecting the laboratory animal against experimental tuberculosis and to be synergic with streptomycin. The combined effects were impressive enough to justify a clinical trial, unfortunately restricted to a limited series (Madigan, Swift, Brownlee and Payling-Wright, 1947) . Simultaneously the drug was under test against leprosy, the case shown to-day being one of the first. Others have been described by Muir (1948) and by Wharton (1947) .
The drug has four sulphonated side chains and is a large molecule. Unlike other diaminodiphenylsulphone derivatives, sulphetrone is not hydrolysed in the body; it is therefore well tolerated and may be exhibited continuously for long periods. This patient has had continuous drug therapy for fifteen months. However, sulphetrone has well-defined hkmatotoxic actions of an interesting kind. It is capable of reacting with alimentary iron to give a non-absorbable complex and thus inducing a hypochromic anvmia. This may be prevented by the administration of adequate amounts of oral iron. Sulphetrone is incompletely absorbed and thus is capable of modifying the micro-flora of the gut. Since biosynthesis is frequently a limiting factor in the supply of essential components of the B vitamin complex, alteration of the flora may cause deficiency states. One is an anxemia of nutritional origin. It was discovered that simultaneous administration of fresh yeast prevented its development. A third anxmia, a hemolytic anxmia associated with crenation of red cells and increased fragility, is caused by drugs of this kind. It is continuous during the period of exhibition and may result in a fall of circulating hemoglobin corresponding to 60% Haldane in extreme cases. The chemotherapy of acid-fast organisms should logically employ the highest blood concentrations that are tolerated by the patient, with the possible advantage of shortening the time of recovery and avoiding the development of resistant strains. Both Muir (1948) and Wharton (1947) gave smaller doses than those employed by Harkness. However, at the blood concentrations employed by all three workers, the problems of toxicity I have mentioned become minute.
An interesting clinical point is that Harkness, treating an intelligent patient, was able to leave the details of drug dosage to his patient. Dr. J. A. O'Connor: Some speakers mentioned the activity of sulphetrone against the tubercle bacillus. Is it not possible that a simpler compound such as para-amino-salicylic acid, which is now being tested in tuberculosis, would be equally efficacious in cases of leprosy? The molecule is much simpler, and the drug appears to be tolerated in very considerable doses, even as high as 10 to 15 grammes a day by mouth. Blood concentrations can be got up to 10 or 15 mg. per 100 ml. of blood. Paraamino-salicylic acid is excreted very rapidly without producing toxic side-effects and I wonder whether Dr. Harkness or Dr. Brownlee has considered the possibility of using some substance such as this in the treatment of leprosy.
Dr. Brownlee: We are only at the beginning of the chemotherapy of this difficult group of organisms and we have all been interested in the report on the chemotherapeutic action of para-amino-salicylic acid. Of course, its application should be encouraged. It should prove a cheaper drug than sulphetrone to make and, should clinical trial prove it to be effective against Mycobacterium tuberculosis, it is likely to prove more effective against My. lepraw.
Dr. O'Connor: This particular drug appears to be unusually potent. I saw some microscopic slides recently from a case of tuberculous empyema. The preliminary slide showed the pleural fluid to contain many polymorph-leucocytes, and thousands of tubercle bacilli were floating free in the liquid. The patient suffered from a bronchopleural fistula for which she was receiving penicillin; 2 grammes of para-amino-salicylic acid had been injected into the empyema. Examination of the empyema fluid a week later showed that 82 % of the tubercle bacilli had been phagocytosed. Whether this was due to the combination of the drug with penicillin I do not know, but the fact remains that there was this marked degree of phagocytosis and perhaps the same thing could occur in other diseases due to acid-fast bacilli.
The following case was also shown: Erythema Elevatum Diutinum.-Dr. E. LIPMAN COHEN. (This case may be published later in the British Journal of Dermatology.)
